102. Transatlantic Milestones in Infection Control: Where are the European Union and the United States Now?
Friday, October 4, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: 135 (Hall E)
Co-organized with the European Centre for Disease Prevention and Control and developed in collaboration with the U.S. Centers for Disease Control and Prevention

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the prevalence of key antimicrobial resistance pathogens and healthcare-associated infections (HAIs), and frequently used antimicrobials, in the United States and the European Union
  • list the key elements necessary to develop infection control programs in European hospitals
  • describe necessary actions to prevent importation and spread of antimicrobial-resistant bacteria in hospitals

Target Audience: scientists, researchers, public health practitioners, pharmacists, nurses, microbiologists, members-in-training, investigators, infectious diseases physicians, infectious diseases pediatricians, infection preventionists, hospital epidemiologists, hospital administrators, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderator:  Carl Suetens, MD, European Centre for Disease Prevention and Control

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-078-L05-P


C. Suetens, None

C. Suetens, None

A. P. Magiorakos, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.